Skip to Content

L48 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint L48 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Macleods Pharmaceuticals Limited.

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L48

Darifenacin Hydrobromide Extended-Release

Imprint
L48
Strength
7.5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
Manufacturer
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
33342-0276
Inactive Ingredients
calcium phosphate dibasic anhydrous, silicon dioxide, magnesium stearate, magnesium silicate, titanium dioxide, hypromelloses, polyethylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "L48"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.